BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 154 filers reported holding BIODELIVERY SCIENCES INTL IN in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | – | 1,000 | +2841.2% | 0.00% | – |
Q2 2021 | $0 | – | 34 | -71.2% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 118 | -100.0% | 0.00% | – |
Q1 2016 | $1,652,000 | -87.2% | 511,479 | -81.1% | 0.00% | -100.0% |
Q4 2015 | $12,949,000 | +280.3% | 2,703,352 | +341.4% | 0.00% | – |
Q3 2015 | $3,405,000 | -34.6% | 612,456 | -6.4% | 0.00% | -100.0% |
Q2 2015 | $5,208,000 | -24.3% | 654,299 | -0.1% | 0.00% | 0.0% |
Q1 2015 | $6,877,000 | -72.8% | 654,999 | -68.9% | 0.00% | -66.7% |
Q4 2014 | $25,308,000 | -37.8% | 2,105,499 | -11.5% | 0.00% | -50.0% |
Q3 2014 | $40,676,000 | +25.6% | 2,380,099 | -11.3% | 0.01% | +50.0% |
Q2 2014 | $32,384,000 | +26.0% | 2,682,983 | -11.9% | 0.00% | 0.0% |
Q1 2014 | $25,705,000 | +49.1% | 3,045,583 | +4.0% | 0.00% | +100.0% |
Q4 2013 | $17,244,000 | -44.2% | 2,927,631 | -48.5% | 0.00% | -60.0% |
Q3 2013 | $30,893,000 | +46.7% | 5,689,300 | +9.7% | 0.01% | +66.7% |
Q2 2013 | $21,056,000 | – | 5,186,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |